Characteristic | No. (%) | p value* | |||
---|---|---|---|---|---|
Placebo control n = 88 | Video n = 88 | Video–sucrose n = 87 | Video–sucrose–lidocaine n = 86 | ||
At 2 mo | |||||
Pallor | 46 (52.3) | 43 (48.9) | 51 (58.6) | 61 (71.8)† | 0.01 |
Redness | 62 (70.4) | 57 (64.8) | 62 (71.3) | 69 (80.2) | 0.2 |
At 4 mo | n = 82 | n = 78 | n = 77 | n = 76 | |
Pallor | 29 (35.4) | 34 (43.6) | 36 (46.7) | 39 (51.3) | 0.2 |
Redness | 48 (58.5) | 48 (61.5) | 48 (62.3) | 51 (67.1) | 0.7 |
At 6 mo | n = 81 | n = 75 | n = 79 | n = 74 | |
Pallor | 26 (32.1) | 27 (36.0) | 28 (35.4) | 38 (51.4) | 0.07 |
Redness | 45 (56.0) | 44 (58.7) | 47 (59.5) | 47 (63.5) | 0.8 |
At 12 mo | n = 76 | n = 75 | n = 77 | n = 71 | |
Pallor | 31 (40.8) | 35 (46.7) | 40 (51.9) | 33 (46.5) | 0.6 |
Redness | 50 (65.8) | 48 (64.0) | 53 (68.8) | 53 (74.6) | 0.5 |